Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

[Hoarsness after a trip to the United States of America].

Nobile A, Schüpbach RA, Flepp M, Maggiorini M, Günthard H, Zinkernagel AS.

Praxis (Bern 1994). 2013 Oct 30;102(22):1377-81. doi: 10.1024/1661-8157/a001469. German.

PMID:
24169483
2.

Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study.

Weber R, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, Cavassini M, Calmy A, Bernasconi E, Schmid P, Flepp M, Kowalska J, Ledergerber B; Swiss HIV Cohort Study (SHCS).

HIV Med. 2013 Apr;14(4):195-207. doi: 10.1111/j.1468-1293.2012.01051.x. Epub 2012 Sep 24.

PMID:
22998068
3.

High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease.

Schüpbach J, Bisset LR, Regenass S, Bürgisser P, Gorgievski M, Steffen I, Andreutti C, Martinetti G, Shah C, Yerly S, Klimkait T, Gebhardt M, Schöni-Affolter F, Rickenbach M; Swiss HIV Cohort Study, Barth J, Battegay M, Bernascon E, Böni J, Bucher HC, Bürgisser P, Burton-Jeangros C, Calmy A, Cavassini M, Dubs R, Egger M, Elzi L, Fehr J, Fischer M, Flepp M, Francioli P, Furrer H, Fux CA, Gorgievski M, Günthard H, Hasse B, Hirsch HH, Hirschel B, Hösli I, Kahlert C, Kaiser L, Keiser O, Kind C, Klimkait T, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Müller N, Nadal D, Pantaleo G, Rauch A, Regenass S, Rickenbach M, Rudin C, Schmid P, Schultze D, Schöni-Affolter F, Schüpbach J, Speck R, Taffé P, Telenti A, Trkola A, Vernazza P, von Wyl V, Weber R, Yerly S.

BMC Infect Dis. 2011 Sep 26;11:254. doi: 10.1186/1471-2334-11-254.

4.

Lipid and lipoprotein profile in HIV-infected patients treated with lopinavir/ritonavir as a component of the first combination antiretroviral therapy.

Magenta L, Dell-Kuster S, Richter WO, Young J, Hasse B, Flepp M, Hirschel B, Vernazza P, Evison J, Cavassini M, Decosterd LA, Bucher HC, Bernasconi E; Swiss HIV Cohort Study (SHCS).

AIDS Res Hum Retroviruses. 2011 May;27(5):525-33. doi: 10.1089/aid.2010.0207. Epub 2010 Nov 22.

PMID:
20854107
5.

High prevalence of anorectal chlamydial infection in HIV-infected men who have sex with men in Switzerland.

Dang T, Jaton-Ogay K, Flepp M, Kovari H, Evison JM, Fehr J, Schmid P, Boffi El Amari E, Cavassini M, Odorico M, Tarr PE, Greub G.

Clin Infect Dis. 2009 Nov 15;49(10):1532-5. doi: 10.1086/644740.

6.

Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.

Bihl F, Berger C, Chisholm JV 3rd, Henry LM, Bertisch B, Trojan A, Nadal D, Speck RF, Flepp M, Brander C, Mueller NJ; Swiss HIV Cohort Study.

AIDS. 2009 Sep 10;23(14):1918-22. doi: 10.1097/QAD.0b013e3283300a91.

PMID:
19609199
7.

Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.

Kovari H, Ledergerber B, Peter U, Flepp M, Jost J, Schmid P, Calmy A, Mueller NJ, Muellhaupt B, Weber R; Swiss HIV Cohort Study.

Clin Infect Dis. 2009 Aug 15;49(4):626-35. doi: 10.1086/603559.

8.

HIV transmission under highly active antiretroviral therapy.

Vernazza P, Hirschel B, Bernasconi E, Flepp M.

Lancet. 2008 Nov 22;372(9652):1806-7; author reply 1807. doi: 10.1016/S0140-6736(08)61753-5. No abstract available.

PMID:
19027479
9.

Partial deletion of CYP2B6 owing to unequal crossover with CYP2B7.

Rotger M, Saumoy M, Zhang K, Flepp M, Sahli R, Decosterd L, Telenti A; Swiss HIV Cohort Study.

Pharmacogenet Genomics. 2007 Oct;17(10):885-90.

PMID:
17885627
10.

Two versus three-class antiretroviral therapy in antiretroviral-naive patients in different time periods of the HAART era.

Taffé P, Bucher HC, Flepp M, Battegay M.

AIDS. 2007 Feb 19;21(4):537-8. No abstract available.

PMID:
17301581
11.

HIV replication elicits little cytopathic effects in vivo: analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell death.

Funk GA, Oxenius A, Fischer M, Opravil M, Joos B, Flepp M, Weber R, Günthard HF, Bonhoeffer S.

J Med Virol. 2006 Sep;78(9):1141-6.

PMID:
16847964
12.

Tenofovir-containing nucleoside/nucleotide-only antiretroviral maintenance therapy: decision making and virological outcome.

Buehlmann M, Chave JP, Flepp M, Schiffer V, Keiser O, Furrer H.

HIV Clin Trials. 2006 Mar-Apr;7(2):48-54.

PMID:
16798619
13.

Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy.

Bertschy S, Opravil M, Cavassini M, Bernasconi E, Schiffer V, Schmid P, Flepp M, Chave JP, Christen A, Furrer H; Swiss HIV Cohort Study.

Clin Microbiol Infect. 2006 Jul;12(7):666-71.

14.

Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trial.

Hürlimann D, Chenevard R, Ruschitzka F, Flepp M, Enseleit F, Béchir M, Kobza R, Muntwyler J, Ledergerber B, Lüscher TF, Noll G, Weber R.

Heart. 2006 Jan;92(1):110-2. Epub 2005 Mar 29. No abstract available.

15.

Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control study.

Hasse B, Ledergerber B, Egger M, Flepp M, Bachmann S, Bernasconi E, Egger M, Guyot S, Hirschel B, Weber R, Günthard HF; Swiss HIV Cohort Study.

AIDS Res Hum Retroviruses. 2004 Sep;20(9):909-15.

PMID:
15597520
16.

Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia: prospective multicentre study.

Zellweger C, Opravil M, Bernasconi E, Cavassini M, Bucher HC, Schiffer V, Wagels T, Flepp M, Rickenbach M, Furrer H; Swiss HIV Cohort Study.

AIDS. 2004 Oct 21;18(15):2047-53.

PMID:
15577626
17.
18.

Gynecomastia and potent antiretroviral therapy.

Strub C, Kaufmann GR, Flepp M, Egger M, Kahlert C, Cavassini M, Battegay M; Swiss HIV Cohort Study.

AIDS. 2004 Jun 18;18(9):1347-9. No abstract available.

PMID:
15362673
19.

Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol.

Rusert P, Fischer M, Joos B, Leemann C, Kuster H, Flepp M, Bonhoeffer S, Günthard HF, Trkola A.

Virology. 2004 Aug 15;326(1):113-29.

PMID:
15262500
20.

Infrequent transmission of HIV-1 drug-resistant variants.

Yerly S, Jost S, Telenti A, Flepp M, Kaiser L, Chave JP, Vernazza P, Battegay M, Furrer H, Chanzy B, Burgisser P, Rickenbach M, Gebhardt M, Bernard MC, Perneger T, Hirschel B, Perrin L; Swiss HIV Cohort Study.

Antivir Ther. 2004 Jun;9(3):375-84.

PMID:
15259900
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk